Expression and Significance of PKR,p-PKR and p-EIF2α in Human Cervical Lesions
10.3969/j.issn.0253-9896.2010.01.007
- VernacularTitle:宫颈病变组织中PKR、p-PKR、p-EIF2α表达及意义
- Author:
Yuancai LUO
;
Quanxin QU
;
Ruoran MI
- Publication Type:Journal Article
- Keywords:
uterine cervical neoplasms;
carcinoma;
cervical intraepithelial neoplasia;
protein kinases;
eukaryotic;
initiation factor-2;
immunohistochemistry
- From:
Tianjin Medical Journal
2010;38(1):20-22,后插1
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To identify the relationship between expression of protein kinase R(PKR), phosphating PKR, EIF2α(p-PKR, p-EIF2α) in PKR→EIF2α signal transduction passage and the grades of cervical lesions, the role in generation and progression of cervical tumor and their effects to prognosis of cervical cancer patients. Methods:The expressions of PKR, p-PKR and p-EIF2α in human cervical cancer tissue of 63 cases, cervical intraepithelial neoplasia(CINⅠ-Ⅲ) of 114 cases and normal cervical epithelium of 15 cases were detected by immunohistochemical technique. Results:With the increase in grades of cervical lesions, the positive-expression rate of PKR increased and significantly correlated with the grades of cervical lesions(P < 0.05). With the increase in grades of cervical lesions, the positive-expression rates of p-PKR and p-EIF2α increased firstly, and then decreased. In cervical cancer group, the positive-expression rate of PKR was much higher than that of p-PKR(P < 0.01). The development and progression was quicker in later clinical stages of cervical cancer than that of earlier clinical stages of cervical cancer (P < 0.01). The development and progression of cervical cancer was quicker in patients with negative-expression of p-PKR and p-EIF2α than that in patients with positive-expression of p-PKR and p-EIF2α(P < 0.05). Conclusion:The positive-expression rate of PKR was correlated with the grades of cervical lesions. There are some factors which can impede PKR and EIF2α to be phosphorylated or make p-PKR and p-EIF2α dephosphorylate in high level cervical lesions, which promotes the development and progression of cervical lesions, worsens the prognosis of cervical cancer.
